Literature DB >> 28592965

Is there any link between homocysteine and atherosclerosis?

Hamza Duygu1.   

Abstract

Entities:  

Keywords:  Atherosclerosis; Homocysteine; Risk factors

Year:  2017        PMID: 28592965      PMCID: PMC5460068          DOI: 10.11909/j.issn.1671-5411.2017.03.001

Source DB:  PubMed          Journal:  J Geriatr Cardiol        ISSN: 1671-5411            Impact factor:   3.327


× No keyword cloud information.
I have read with interest the paper by Han, et al.[1] reporting that homocysteine (Hcy) is an independent risk factor for non-culprit coronary lesions progression after 12 months of follow-up in elderly patients who has undergone percutaneous coronary stenting. Hcy-mediated increased lipid peroxidation and generation of free radicals results in inflammation and endothelial dysfunction, which triggers atherosclerotic process. Coronary artery disease is also associated with higher levels of Hcy.[2] Hcy is formed in the body from methionin. Methionin is metabolised via re-methylation and transsulphuration. These processes depend on vitamins B12, B6 and folic acid.[3] The major determinants of plasma homocysteine level are B vitamins and folate intake and genetic factors.[3] Plasma Hcy levels are negatively correlated with vitamin B12, folic acid and creatinine levels. Thus, reporting of these parameters in elderly population would be appropriate in this particular study. Conventional coronary angiography only demonstrates plaque that encroaches on the lumen. Due to shortcomings of conventional coronary angiography, intravascular imaging provides additional anatomic information regarding vessel wall changes in atherosclerosis. Intravascular ultrasound (IVUS) allows the direct visualization of the arterial wall and atherosclerosis.[4] IVUS would be useful in terms of evaluating the progression of atherosclerotic process more accurately.
  4 in total

1.  OCT versus IVUS: accuracy versus clinical utility.

Authors:  Akiko Maehara; Gary S Mintz; Gregg W Stone
Journal:  JACC Cardiovasc Imaging       Date:  2013-10

Review 2.  The role of homocysteine-lowering B-vitamins in the primary prevention of cardiovascular disease.

Authors:  Balazs Debreceni; Laszlo Debreceni
Journal:  Cardiovasc Ther       Date:  2014-06       Impact factor: 3.023

3.  A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. Probable benefits of increasing folic acid intakes.

Authors:  C J Boushey; S A Beresford; G S Omenn; A G Motulsky
Journal:  JAMA       Date:  1995-10-04       Impact factor: 56.272

4.  Homocysteine is associated with the progression of non-culprit coronary lesions in elderly acute coronary syndrome patients after percutaneous coronary intervention.

Authors:  Tian-Wen Han; Shan-Shan Zhou; Jian-Tao Li; Feng Tian; Yang Mu; Jing Jing; Yun-Feng Han; Yun-Dai Chen
Journal:  J Geriatr Cardiol       Date:  2016-05       Impact factor: 3.327

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.